Euda Health signs MOU with GO POSB Organoids, Shenzhen Inno on iPSC-derived oncology cell therapies

Reuters2026/07/28 20:32

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Euda Health signed a tri-party MOU with GO POSB Organoids, Shenzhen Innovation Immunotechnology to collaborate on iPSC-derived cell therapies.
Parties target development, manufacturing, commercialization of off-the-shelf oncology cell therapies, including iPSC-based NK-TCR programs.
Collaboration supports Euda’s strategy to expand distribution of science-backed wellness, non-invasive healthcare offerings across Asia.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euda Health Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-035013), on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Euda Health signs MOU with GO POSB Organoids, Shenzhen Inno on iPSC-derived oncology cell therapies

You may also like

Crypto prices